Calm, accurate health journalism. Weekly explainers on nutrition, fitness, sleep, and the science of feeling better.

Eli Lilly launches a groundbreaking Phase 3 trial comparing its oral GLP-1 pill Foundayo with the injectable Zepbound, targeting obesity…

In a strategic move, Novo Nordisk will conduct a pivotal trial comparing its oral semaglutide against Wegovy, entering a competitive…

In a landmark decision, the FDA has approved Foundayo, the first oral GLP-1 receptor agonist for chronic weight management, offering…

A groundbreaking discovery of a new peptide molecule offers the potential for weight-loss solutions without the adverse effects linked to…

Researchers using advanced MRI technology have identified a previously unknown waste-removal pathway in the human brain that flows along the…

Researchers at Stanford University’s Sleep Medicine Center announced this morning that their new six-week ‘Circadian Reset’ protocol has shown remarkable…